Skip to main content

Beneficial ownership — 13D / 13G

87,240 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Millennium Management LLC CDMO Avid Bioservices, Inc. Common Stock 13G 7.3% 2y
PL Capital Advisors, LLC BANC Banc Of California, Inc. 13D/A 1.9% 2y
Findell Capital Partners LP EHTH eHealth, Inc. 13G 5.1% 2y
NewGen Asset Management Ltd ELBM Electra Battery Materials Corp 13G 9.9% 2y
Peter J. Nolan LMNR Limoneira CO 13D/A 6.1% 2y
HGGC Fund IV GP, Ltd. UPLD Upland Software, Inc. 13D/A 18.85% 2y
Richard Gebbia SIEB Siebert Financial Corp 13D/A 43% 2y
Meridian Venture Partners II GP, L.P. ("GP") ANIP Ani Pharmaceuticals Inc 13D/A 8.2% 2y
Ming Ni MATH Metalpha Technology Holding Ltd 13D/A 7.9% 2y
Fosun International Ltd LANV Lanvin Group Holdings Ltd 13D/A 58.65% 2y
Saba Capital Management, L.P. MPA Blackrock Muniyield Pennsylvania Quality Fund 13D/A 14.55% 2y
Saba Capital Management, L.P. SABA Saba Capital Income & Opportunities Fund II 13D/A 15.89% 2y
BAKER BROS. ADVISORS LP SGEN Seagen Inc. Common Stock 13D/A 0% 2y
Saba Capital Management, L.P. NBH Neuberger Municipal Fund Inc. 13D/A 6.38% 2y
Deerfield Management Company, L.P. FUSN Fusion Pharmaceuticals Inc. Common Shares 13G 8.84% 2y
APA Corporation KNTK Kinetik Holdings Inc. 13D/A 22.9% 2y
CLEARLAKE CAPITAL GROUP, L.P. JBI Janus International Group, Inc. 13D/A 0% 2y
Xianqun Hu MATH Metalpha Technology Holding Ltd 13G 8.8% 2y
SR One Capital Management, LLC ACLX Arcellx, Inc. 13D/A 6.46% 2y
Summer Road LLC OCUL Ocular Therapeutix, Inc 13D/A 11.6% 2y
Damien Lamendola MRAI Marpai, Inc. 13D/A 28.5% 2y
Cosmic Forward Limited IPDN Professional Diversity Network, Inc. 13D/A 24.05% 2y
TCI FUND MANAGEMENT LTD MCO Moodys Corp 13G/A 6.54% 2y
Theofilos Charles Steve ECOR electroCore, Inc. 13D 9.9% 2y
Divisadero Street Capital Management, LP GRPN Groupon, Inc. 13G 4.6% 2y
Point72 Asset Management, L.P. PTGX Protagonist Therapeutics, Inc 13G 5.5% 2y
Portolan Capital Management, LLC GENK GEN Restaurant Group, Inc. 13G 6.66% 2y
D. E. Shaw & Co., L.P. PLCE Childrens Place, Inc. 13G/A 6% 2y
GOLDENTREE ASSET MANAGEMENT LP ECHO EchoStar CORP 13G 5.7% 2y
MAK CAPITAL ONE LLC HTOO Fusion Fuel Green PLC 13G 17.3% 2y
Mark W.B. Harms VWE Vintage Wine Estates, Inc. Common Stock 13D/A 50% 2y
Joshua M. Hare, M.D. LGVN Longeveron Inc. 13D/A 48.3% 2y
Symetryx Corporation MBAI MBody AI Ltd. 13D/A 5.8% 2y
Samsara BioCapital, L.P. IOBTQ IO Biotech, Inc. 13G 5.5% 2y
KNIGHT THERAPEUTICS INC. SXTP 60 Degrees Pharmaceuticals, Inc. 13G 19.9% 2y
Cooper Road, LLC NB Niocorp Developments Ltd 13G 8.6% 2y
RUFFLE JOHN F AMS American Shared Hospital Services 13D/A 6.5% 2y
Jacobsen Per A. BLIN Bridgeline Digital, Inc. 13G/A 6.7% 2y
BAKER BROS. ADVISORS LP IGMS IGM Biosciences, Inc. Common Stock 13D/A 11.4% 2y
Angeliki Frangou NMPGY Navios Maritime Holdings Inc. 13D/A 100% 2y
NOVO HOLDINGS A/S OKUR OnKure Therapeutics, Inc. 13D/A 0% 2y
Strategic Value Partners, LLC SBOW SilverBow Resources, Inc. 13D/A 1.5% 2y
Timothy K. Bliss APPF Appfolio Inc 13D/A 4.95% 2y
Sherborne Investors Management LP NAVI Navient Holdings, Inc. 13D/A 25% 2y
Focused Compounding Fund, LP PRKA Parks America, Inc 13D/A 38.5% 2y
ORBIMED ADVISORS LLC IRON Disc Medicine, Inc. 13D/A 7.1% 2y
Transcend Partners Opportunity Fund LLC INAB In8bio, Inc. 13G/A 7.5% 2y
Elliott Investment Management L.P. BTU Peabody Energy Corp 13D/A 11.4% 2y
BIOS FUND II, LP INAB In8bio, Inc. 13D/A 23.1% 2y
Wasef Jabsheh IGIC International General Insurance Holdings Ltd. 13D/A 30.9% 2y